JG
SAGE

Jain Global’s Sage Therapeutics SAGE Stock Holding History

Jain Global’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-46,085
Closed -$250K – 1310
2024
Q4 		$250K Buy
+46,085
New +$282K 0.01% 592

Other funds holding SAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Jain Global's SAGE Position: Q1 2025 in Review

Jain Global sold out of Sage Therapeutics (SAGE) in Q1 2025, closing a stake of 46,085 shares — an estimated $250K sold.

Jain Global first reported a position in SAGE in Q4 2024 and held it in 1 quarter. The position peaked at $250K in Q4 2024. 197 funds tracked by Wall St. Rank hold SAGE as of Q1 2025.

  • Jain Global reported no remaining Sage Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Jain Global sold 46,085 Sage Therapeutics shares in Q1 2025, an estimated $250K.
  • Jain Global first reported a position in Sage Therapeutics in Q4 2024 and held it in 1 quarter.
  • Jain Global's Sage Therapeutics position peaked at $250K in Q4 2024.
  • 197 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2025.

Based on Jain Global's 13F filing for Q1 2025, filed 15 May 2025.